A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

  1. Schmidt, W.A.
  2. Dasgupta, B.
  3. Sloane, J.
  4. Giannelou, A.
  5. Xu, Y.
  6. Unizony, S.H.
  7. Mackie, S.L.
  8. Gonzalez-Gay, M.A.
  9. Spiera, R.
  10. Warrington, K.J.
  11. Villiger, P.M.
  12. Nivens, M.C.
  13. Akinlade, B.
  14. Lin, Y.
  15. Buttgereit, F.
  16. Stone, J.H.
Revista:
Arthritis Research and Therapy

ISSN: 1478-6362,  1478-6354

Ano de publicación: 2023

Volume: 25

Número: 1

Tipo: Artigo

DOI: 10.1186/S13075-023-03177-6 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus